» Articles » PMID: 20010345

Transanal Endoscopic Microsurgery Resection of Rectal Tumors: Outcomes and Recommendations

Overview
Specialty Gastroenterology
Date 2009 Dec 17
PMID 20010345
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Transanal endoscopic microsurgery provides a minimally invasive alternative to radical surgery for excision of benign and malignant rectal tumors. The purpose of this study was to review our experience with transanal endoscopic microsurgery to clarify its role in the treatment of different types of rectal pathology.

Methods: A prospective database documented all patients undergoing transanal endoscopic microsurgery from October 1996 through June 2008. We analyzed patient and operative factors, complications, and tumor recurrence. For recurrence analysis, we excluded patients with fewer than 6 months of follow-up, previous excisions, known metastases at initial presentation, and those who underwent immediate radical resection following transanal endoscopic microsurgery.

Results: Two hundred sixty-nine patients underwent transanal endoscopic microsurgery for benign (n = 158) and malignant (n = 111) tumors. Procedure-related complications (21%) included urinary retention (10.8%), fecal incontinence (4.1%), fever (3.8%), suture line dehiscence (1.5%), and bleeding (1.5%). Local recurrence rates for 121 benign and 83 malignant tumors were 5% for adenomas, 9.8% for T1 adenocarcinoma, 23.5% for T2 adenocarcinoma, 100% for T3 adenocarcinoma, and 0% for carcinoid tumors. All 6 (100%) recurrent adenomas were retreated with endoscopic techniques, and 8 of 17 (47%) recurrent adenocarcinomas underwent salvage procedures with curative intent.

Conclusions: Transanal endoscopic microsurgery is a safe and effective method for excision of benign and malignant rectal tumors. Transanal endoscopic microsurgery can be offered for (1) curative resection of benign tumors, carcinoid tumors, and select T1 adenocarcinomas, (2) histopathologic staging in indeterminate cases, and (3) palliative resection in patients medically unfit or unwilling to undergo radical resection.

Citing Articles

Post-transanal endoscopic microsurgery (TEM) syndrome: a constellation of symptoms resulting from localized inflammatory changes after TEM.

Robertson R, Johnson G, Vergis A, Karimuddin A, Phang T, Raval M Can J Surg. 2025; 68(1):E73-E79.

PMID: 40010852 PMC: 11879369. DOI: 10.1503/cjs.012223.


Efficacy and safety of transanal endoscopic microsurgery for early rectal cancer: a meta-analysis.

Wang C, Huang T, Wang X Front Oncol. 2025; 15:1545547.

PMID: 39995839 PMC: 11847824. DOI: 10.3389/fonc.2025.1545547.


Current Surgical Methods in Local Rectal Excision.

Semanjski K, Luzaic K, Brkic J Gastrointest Tumors. 2024; 10(1):44-56.

PMID: 39015761 PMC: 11249472. DOI: 10.1159/000538958.


Excision of malignant and pre-malignant rectal lesions by transanal endoscopic microsurgery in patients under 50 years of age.

Shilo Yaacobi D, Berger Y, Shaltiel T, Bekhor E, Khalifa M, Issa N World J Gastrointest Surg. 2023; 15(9):1892-1900.

PMID: 37901725 PMC: 10600772. DOI: 10.4240/wjgs.v15.i9.1892.


Prognosis of Patients Over 60 Years Old With Early Rectal Cancer Undergoing Transanal Endoscopic Microsurgery - A Single-Center Experience.

Zhang M, Zhang Y, Jing H, Zhao L, Xu M, Xu H Front Oncol. 2022; 12:888739.

PMID: 35774121 PMC: 9239430. DOI: 10.3389/fonc.2022.888739.